These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16321449

  • 1. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis.
    Ichiyama T, Kajimoto M, Suenaga N, Maeba S, Matsubara T, Furukawa S.
    J Neuroimmunol; 2006 Mar; 172(1-2):182-6. PubMed ID: 16321449
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
    Ichiyama T, Siba P, Suarkia D, Takasu T, Miki K, Kira R, Kusuhara K, Hara T, Toyama J, Furukawa S.
    J Neurol Sci; 2007 Jan 15; 252(1):45-8. PubMed ID: 17118404
    [Abstract] [Full Text] [Related]

  • 3. Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.
    Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.
    Ann Rheum Dis; 2001 Sep 15; 60(9):846-51. PubMed ID: 11502611
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C, Ozmenoglu M, Velioglu S, Kilinc K, Orem A, Alioglu Z, Altunayoglu V.
    Clin Neurol Neurosurg; 2006 Feb 15; 108(2):124-8. PubMed ID: 16412833
    [Abstract] [Full Text] [Related]

  • 5. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
    Salata IM, Stojanovic N, Cajdler-Łuba A, Lewandowski KC, Lewiński A.
    Gynecol Endocrinol; 2008 Jun 15; 24(6):326-30. PubMed ID: 18584412
    [Abstract] [Full Text] [Related]

  • 6. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J, Hua Q, Xing X, Wen J, Liu R, Yang Z.
    Hypertens Res; 2007 Oct 15; 30(10):959-63. PubMed ID: 18049028
    [Abstract] [Full Text] [Related]

  • 7. Tissue inhibitors of matrix metalloproteinase-1 levels are increased in serum of patients with allergic contact dermatitis.
    Reduta T, Laudańska H, Laudanski P.
    Contact Dermatitis; 2007 Aug 15; 57(2):100-4. PubMed ID: 17627649
    [Abstract] [Full Text] [Related]

  • 8. Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures.
    Suenaga N, Ichiyama T, Kubota M, Isumi H, Tohyama J, Furukawa S.
    J Neurol Sci; 2008 Mar 15; 266(1-2):126-30. PubMed ID: 17928006
    [Abstract] [Full Text] [Related]

  • 9. Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients. One year follow-up results.
    Karabudak R, Kurne A, Guc D, Sengelen M, Canpinar H, Kansu E.
    J Neurol; 2004 Mar 15; 251(3):279-83. PubMed ID: 15015006
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia.
    Sunagawa S, Ichiyama T, Honda R, Fukunaga S, Maeba S, Furukawa S.
    Brain Dev; 2009 Sep 15; 31(8):588-93. PubMed ID: 18849127
    [Abstract] [Full Text] [Related]

  • 11. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B, Głowińska B, Urban M, Peczyńska J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Sep 15; 12(3):184-9. PubMed ID: 17020653
    [Abstract] [Full Text] [Related]

  • 12. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z.
    J Nephrol; 2007 Sep 15; 20(4):444-52. PubMed ID: 17879211
    [Abstract] [Full Text] [Related]

  • 13. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
    Belo VA, Souza-Costa DC, Lana CM, Caputo FL, Marcaccini AM, Gerlach RF, Bastos MG, Tanus-Santos JE.
    Clin Biochem; 2009 Jul 15; 42(10-11):984-90. PubMed ID: 19358835
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H, Oktay G, Terzi C, Canda AE, Füzün M, Küpelioğlu A.
    Cell Biochem Funct; 2007 Jul 15; 25(4):433-41. PubMed ID: 16615041
    [Abstract] [Full Text] [Related]

  • 15. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis.
    Palus M, Zampachová E, Elsterová J, Růžek D.
    J Infect; 2014 Feb 15; 68(2):165-9. PubMed ID: 24091083
    [Abstract] [Full Text] [Related]

  • 16. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH, Karalis I, Nadar SK, Beevers DG, MacFadyen RJ, Lip GY.
    Am J Hypertens; 2005 Mar 15; 18(3):325-9. PubMed ID: 15797648
    [Abstract] [Full Text] [Related]

  • 17. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.
    Rheumatology (Oxford); 2006 Apr 15; 45(4):414-20. PubMed ID: 16287916
    [Abstract] [Full Text] [Related]

  • 18. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM, Jacob-Ferreira AL, Gomes VA, Casella-Filho A, Chagas AC, Marcaccini AM, Gerlach RF, Tanus-Santos JE.
    Clin Chim Acta; 2009 May 15; 403(1-2):173-7. PubMed ID: 19254704
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteases and their tissue inhibitor in cardiac transplantation.
    Aharinejad S, Krenn K, Zuckermann A, Schäfer R, Paulus P, Seebacher G, Wolner E, Grimm M.
    Eur J Cardiothorac Surg; 2007 Jul 15; 32(1):48-51. PubMed ID: 17482473
    [Abstract] [Full Text] [Related]

  • 20. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET.
    Shibahara H, Suzuki T, Kikuchi K, Hirano Y, Suzuki M.
    Am J Reprod Immunol; 2005 Oct 15; 54(4):186-92. PubMed ID: 16135009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.